- Headquarters
- Seattle, Washington
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- vilyatx.com
- Total Funding
- $71.0M
- Last Round
- $21.0M Series AJun 2024
About
Computational biotechnology company designing de novo macrocycles with AI for therapeutic drug discovery.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account